Lifelong Medical, Psychosocial, and Economic Burden of Infant-Onset Invasive Meningococcal Disease in the US: Insights from a Delphi Panel Study

Oscar Herrera-Restrepo, GlaxoSmithKline (GSK), Philadelphia, PA, United States; Patrice Carter, Health Economics Outcomes Research Ltd, Cardiff, Wales, United Kingdom; Amy Gamble, University of Birmingham, Birmingham, England, United Kingdom; Tosin Olaiya, GSK, Philadelphia, PA, United States; Kristin K. Johnson, GSK, Philadelphia, PA, United States; Thatiana Pinto, GSK, Brussels, Brussels Hoofdstedelijk Gewest, Belgium; Jana Shaw, Upstate Golisano Children's Hospital, Syracuse, NY, United States; Joseph Domachowske, Upstate Golisano Children's Hospital, Syracuse, NY, United States; Gary S. Marshall, University of Louisville School of Medicine, Louisville, KY, United States